Dyadic International Files 8-K with Material Agreement
Ticker: DYAI · Form: 8-K · Filed: Nov 26, 2024 · CIK: 1213809
| Field | Detail |
|---|---|
| Company | Dyadic International Inc (DYAI) |
| Form Type | 8-K |
| Filed Date | Nov 26, 2024 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001, $3,092,136.00 |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-agreement, filing, corporate-action
Related Tickers: DYAI
TL;DR
Dyadic Intl (DYAI) filed an 8-K on Nov 16, 2024, reporting a material definitive agreement.
AI Summary
On November 16, 2024, Dyadic International, Inc. entered into a Material Definitive Agreement. The filing also includes Regulation FD Disclosure and Financial Statements and Exhibits. The company is incorporated in Delaware and its principal executive offices are located in Jupiter, Florida.
Why It Matters
This 8-K filing indicates a significant development for Dyadic International, Inc., potentially impacting its business operations and investor outlook.
Risk Assessment
Risk Level: medium — Material definitive agreements can introduce new risks or opportunities that are not yet fully understood by the market.
Key Numbers
- 001-32513 — SEC File Number (Identifies the company's filing history with the SEC.)
- 45-0486747 — I.R.S. Employer Identification Number (Company's tax identification number.)
Key Players & Entities
- Dyadic International, Inc. (company) — Registrant
- November 16, 2024 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- Jupiter, FL (location) — Address of principal executive offices
- CCP WORLDWIDE INC (company) — Former company name
FAQ
What is the nature of the Material Definitive Agreement entered into by Dyadic International, Inc. on November 16, 2024?
The filing does not specify the details of the Material Definitive Agreement, only that one was entered into on November 16, 2024.
What are the key items reported in this 8-K filing?
The key items reported are Entry into a Material Definitive Agreement, Regulation FD Disclosure, and Financial Statements and Exhibits.
Where are Dyadic International, Inc.'s principal executive offices located?
Dyadic International, Inc.'s principal executive offices are located at 1044 North U.S. Highway One, Suite 201, Jupiter, FL 33477.
When was Dyadic International, Inc. incorporated?
Dyadic International, Inc. was incorporated in Delaware.
What was the former name of Dyadic International, Inc. and when did the name change occur?
The former name was CCP WORLDWIDE INC, and the date of the name change was January 10, 2003.
Filing Stats: 562 words · 2 min read · ~2 pages · Grade level 10.8 · Accepted 2024-11-26 14:00:34
Key Financial Figures
- $0.001 — ch registered Common Stock , par value $0.001 per share DYAI The NASDAQ Stock Mark
- $3,092,136.00 — ") relating to a grant in the amount of $3,092,136.00 awarded from the Gates Foundation for t
Filing Documents
- dyai20241120_8k.htm (8-K) — 29KB
- ex_751025.htm (EX-10.1) — 52KB
- ex_750590.htm (EX-99.1) — 11KB
- ex_750590img001.jpg (GRAPHIC) — 3KB
- ex_751025img001.jpg (GRAPHIC) — 4KB
- ex_751025img002.jpg (GRAPHIC) — 3KB
- 0001437749-24-036247.txt ( ) — 247KB
- dyai-20241121.xsd (EX-101.SCH) — 3KB
- dyai-20241121_def.xml (EX-101.DEF) — 11KB
- dyai-20241121_lab.xml (EX-101.LAB) — 15KB
- dyai-20241121_pre.xml (EX-101.PRE) — 11KB
- dyai20241120_8k_htm.xml (XML) — 3KB
01
Item 1.01 Entry into a Material Definitive Agreement. On November 16, 2024, Dyadic International, Inc. (the "Company") entered into an agreement (the "Agreement") with the Bill & Melinda Gates Foundation (the "Gates Foundation") relating to a grant in the amount of $3,092,136.00 awarded from the Gates Foundation for the cell line development of monoclonal antibodies targeting respiratory syncytial virus and malaria utilizing the Company's proprietary C1 protein production platform to provide globally accessible treatment options for underserved populations (the "Gates Foundation Grant").
01
Item 7.01 Regulation FD Disclosure. On November 21, 2024, Dyadic International, Inc. (the "Company") issued a press release related to the Gates Foundation Grant. The press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference, other than the third paragraph of the press release.
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits Exhibit Number Description 10.1 (1) Grant Agreement between Dyadic International, Inc. and the Bill & Melinda Gates Foundation, dated as of November 16, 2024 99.1 Dyadic International Press Release Dated November 21, 2024 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) (1) Portions of this exhibit have been omitted pursuant to Item 601(b)(10)(iv) of Regulation S-K.
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: November 26, 2024 Dyadic International, Inc. By: /s/ Mark A. Emalfarb Name: Mark A. Emalfarb Title: Chief Executive Officer